0001209191-15-061133.txt : 20150716
0001209191-15-061133.hdr.sgml : 20150716
20150716150449
ACCESSION NUMBER: 0001209191-15-061133
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150715
FILED AS OF DATE: 20150716
DATE AS OF CHANGE: 20150716
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 15991380
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-07-15
4
M
0
1800
17.16
A
347084
D
Common Stock
2015-07-15
4
M
0
10400
35.64
A
357484
D
Common Stock
2015-07-15
4
S
0
500
131.77
D
356984
D
Common Stock
2015-07-15
4
S
0
2900
133.43
D
354084
D
Common Stock
2015-07-15
4
S
0
8200
134.23
D
345884
D
Common Stock
2015-07-15
4
S
0
600
135.14
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
17.16
2015-07-15
4
M
0
1800
0.00
D
2015-07-19
Common Stock
1800
0
D
Stock Option (right to buy)
35.64
2015-07-15
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
292000
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $131.77 (range $131.20 to $132.15).
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $133.43 (range $132.91 to $133.88).
Open market sales reported on this line occurred at a weighted average price of $134.23 (range $133.91 to $134.87).
Open market sales reported on this line occurred at a weighted average price of $135.14 (range $135.00 to $135.28).
Fully vested.
Omar White, Attorney-In-Fact
2015-07-16